Volume 21, Issue 10 pp. 1334-1337
Short Report

Transient weakness and compound muscle action potential decrement in myotonia congenita

Feza Deymeer MD, MS

Corresponding Author

Feza Deymeer MD, MS

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Çapa, 34390 Istanbul, Turkey

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Çapa, 34390 Istanbul, TurkeySearch for more papers by this author
Sevinnç Çakirkaya MD

Sevinnç Çakirkaya MD

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Çapa, 34390 Istanbul, Turkey

Search for more papers by this author
Piraye Serdaroğlu MD

Piraye Serdaroğlu MD

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Çapa, 34390 Istanbul, Turkey

Search for more papers by this author
Lothar Schleithoff PhD

Lothar Schleithoff PhD

Department of Physiology, University of Ulm, 89069 Ulm, Germany

Search for more papers by this author
Frank Lehmann-Horn MD

Frank Lehmann-Horn MD

Department of Physiology, University of Ulm, 89069 Ulm, Germany

Search for more papers by this author
Reinhardt Rüdel PhD

Reinhardt Rüdel PhD

Department of Physiology, University of Ulm, 89069 Ulm, Germany

Search for more papers by this author
Coşkun Özdemir MD

Coşkun Özdemir MD

Department of Neurology, Istanbul Faculty of Medicine, University of Istanbul, Çapa, 34390 Istanbul, Turkey

Search for more papers by this author

Abstract

Twenty-five Turkish patients with recessive myotonia congenita (RMC), 16 of whom had genetic confirmation, were studied. Nineteen had transient weakness. In the upper extremities, onset age of transient weakness was usually in the early teens. All untreated RMC patients had a compound muscle action potential decrement of ⩾25%, usually above 50%, with repetitive nerve stimulation at 10/s for 5 s. Patients with other nondystrophic diseases with myotonia, except 1 patient with dominant myotonia congenita, had no transient weakness and a CMAP decrement below 25%. © 1998 John Wiley & Sons, Inc. Muscle Nerve 21:1334–1337, 1998.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me